Revenue: The sum of all revenue fields included for a company's operating activities.
LAVA Therapeutics N.V. (LVTX) had Revenue of $11.98M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$11.98M |
$-25.11M |
|
-- |
|
$11.98M |
|
$41.67M |
|
$-29.69M |
|
$5.21M |
|
$-24.48M |
|
$-24.48M |
|
$-25.11M |
|
$-25.11M |
|
$-25.11M |
|
$-25.11M |
|
$-29.69M |
|
$-31.86M |
|
26.83M |
|
26.83M |
|
$-0.94 |
|
$-0.94 |
|
| Balance Sheet Financials | |
$79.30M |
|
$1.00M |
|
$1.53M |
|
$80.83M |
|
$18.01M |
|
$35.00M |
|
$35.08M |
|
$53.09M |
|
$27.75M |
|
$27.75M |
|
$27.75M |
|
26.30M |
|
| Cash Flow Statement Financials | |
$-19.54M |
|
$12.47M |
|
$-0.57M |
|
$44.23M |
|
$35.02M |
|
$-9.22M |
|
$3.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.40 |
|
-- |
|
-- |
|
0.56 |
|
1.44 |
|
100.00% |
|
-247.81% |
|
-247.81% |
|
-265.92% |
|
-204.34% |
|
-209.60% |
|
$-19.48M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-90.52% |
|
-90.52% |
|
-31.07% |
|
-40.03% |
|
$1.05 |
|
$-0.73 |
|
$-0.73 |
|